CN Patent

CN114539225B — 2-氨基-嘧啶类化合物

Assigned to Shanghai Tuojie Biomedical Technology Co ltd · Expires 2024-02-20 · 2y expired

What this patent protects

本公开涉及2‑氨基‑嘧啶类化合物。特别地，本公开提供一种式I所示化合物或其可药用的盐，其中各字母如本文定义的。所述式I所示化合物可作为细胞周期蛋白‑依赖性激酶抑制剂，用于预防和/或治疗与相关的疾病，例如细胞增殖性疾病，癌症或免疫性疾病。

USPTO Abstract

本公开涉及2‑氨基‑嘧啶类化合物。特别地，本公开提供一种式I所示化合物或其可药用的盐，其中各字母如本文定义的。所述式I所示化合物可作为细胞周期蛋白‑依赖性激酶抑制剂，用于预防和/或治疗与相关的疾病，例如细胞增殖性疾病，癌症或免疫性疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN114539225B
Jurisdiction
CN
Classification
—
Expires
2024-02-20
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Tuojie Biomedical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.